Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good general article on immunotherapy:
https://healthguides.healthgrades.com/treating-stage-3-lung-cancer/how-immunotherapy-treats-stage-3-lung-cancer?did=t11_rss4&cb=ap
Heat will get into the dollars this month, sooner rather than later
I am buying the dips now.....but when it gets a little higher I will be selling the rallies then buying the dips ie trading. Right now I am just inclined to accumulate......This stock has a great future.....immunotherapy is king. Going to eradicate cancer
buyers will be the winners at this price
good, I have been loading as well, good stuff, I have a good feeling about today
buy on the dips
the stock looks like it was forced below the 50 day moving average but was finally brought back over for good, I expect tomorrow will be a strong day perhaps back up to .59 or higher.....this stock will be in the dollars very soon....
Dollar land here we come
Don't worry this will keep going
Don't worry this will keep going
We will see the traders jumping on this big time now!
Everywhere I look the pharmaceutical industry is talking about immunotherapy as the best way to treat cancer.....they said that cancer will be beaten by 2024 with immunotherapy.......help the body fight cancer....
We should be hearing about the $6.9 million grant any day. The stock will get back over a buck to keep the reverse split at bay. Hang on for a great ride........Brookline Capital has a target price of $8:
https://biotuesdays.com/2019/07/30/brookline-starts-heat-biologics-at-buy-pt-8/
water is the new gold, I have talked with the management enough to know they have the goods and us shareholders will benefit
This 4th quarter is their quarter, new clinical trials (that will free up a 6.9 million dollar grant), results from other studies etc......so get some bucks for the company while the "purchasers" bask in the knowledge that "promotional material" is forth coming......like shooting fish in a barrel. Ignore the "trend" these are all "fire sale prices" under a buck. Just keep loading loading loading
Good job in your loading.
perfect timing......do a financing to load someone up with shares and then put out all the news forth coming this quarter........including the $6.9 million grant
8K out today I will post it
cancer could be right, i can't get a hold of anyone, I know they had some business opportunities in Israel that were pending, plus some opportunities with citrus growers....a reverse merger would allow their technology to be deployed on a bigger scale
news out this week?
traded below .58 watch by end of day it is back over
GEVO will continue to trend upwards, many more news releases on the horizon
smart, going to be a flurry of news this 4th quarter
stock still holding the line, will get running soon
holding above the 50DMA, soon the chasing will begin propelling the stock to the 200DMA of .99
looking forward to tomorrow's trading activity
The 50 DMA is .58 and the 200 DMA is .99
The stock closed at .6011
Someone tried to knock it down to .57 at the end of the day, but the price was quickly brought back up to over .60 right after.
We should have a run now to .99 which would be a good place to profit take.
GLTA
Enjoy
It is time to cross the 50 DMA
https://stockcharts.com/h-sc/ui?s=htbx
true, everywhere I go I see talk about immunotherapy as the most promising way to battle cancer.....some guy even said that by 2024 cancer would be eradicated because of immunotherapy..........keep our fingers crossed for the cancer patients and our stock
shorts are going to have to back off on this one for now.....is what that previous post should have said
shorts are going to have to back on this one for now
You will see the posting activity increase as the stock climbs.......fasten your seat belts
Brookline Capital Markets launched coverage of Heat Biologics (NASDAQ:HTBX) with a “buy” rating and $8 price target. The stock closed at 52 cents on July 29.
Heat Biologics has cell-therapy platforms called ImPACT and ComPACT, and co-stimulator PTX-35 for boosting CD8+ T-cell activity against cancers by providing cancer antigen-specific activation and co-stimulation.
ImPACT is a vaccine approach for boosting immune activity to fight cancers. HS-110, an ImPACT candidate, is in a Phase 2 trial in non-small cell lung cancer and has shown activity in turning the treated cancers “hot” or more vulnerable for immune recognition, writes analyst Kumaraguru Raja.
“In combination with checkpoint inhibitor like nivolumab, HS-110 can result in a greater tumor response to checkpoint inhibition,” he added.
PTX-35 is a monoclonal antibody agonist utilizing the CD8+ killer T-cell specific pathway. This program is supported by a $15.2-million grant from the Cancer Prevention and Research Institute of Texas. Mr. Raja said a 70-patient first-in-human Phase 1 clinical trial is expected to begin in the fourth quarter of 2019, following an expected IND filing in the third quarter.
ComPACT is in preclinical development and is designed to enhance T-cell activation. A trial with candidate HS-130 is expected to begin in the third quarter of 2019, with interim data potentially in the first quarter of 2020, Mr. Raja added.
https://biotuesdays.com/2019/07/30/brookline-starts-heat-biologics-at-buy-pt-8/
Great idea, you might want to keep adding to this one now........should be back over a buck.......very quietly and consistently......someone is on the accumulation path
the ask 1's will quickly disappear when this is ready
FNRC will be a copycat of VSHC, where they will get cash, buying back shares, and assets added to the company.
FNRC will be one of the best performing stocks. This thought scares the begeebees out of the short sellers. They have sold over the years millions of shares for virtually nothing. They put a hundred bucks in their pocket for a million shares. Now when this thing comes alive they are instantly in trouble.
They are powerless, the company is hibernating in a financial statement desert. So the shorts do not know what is happening. When the s**t hits the fan. They gotta chase.
we should have a floor here
haven't heard but there is another one in China
https://www.heatbio.com/news-media/news-releases/detail/630/heat-biologics-lead-director-to-present-at-the-chinabio
thanks
tried to buy in Canada and could not, I heard this is going to .50